Related Experiment Video

Updated: Jul 2, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K

The National Non-Hodgkin Lymphoma Audit: Insights and Impact

R Kanani1, K Walker2, L Han2

  • 1Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK.

Clinical Oncology (Royal College of Radiologists (Great Britain))
|February 27, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Auditnon-Hodgkin lymphomaoutcomesquality improvement

More Related Videos

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.5K

Related Experiment Videos

Last Updated: Jul 2, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

14.3K
HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

11.7K
Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.5K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Articles linked to this work by shared authors, journal, and citation graph.

Prevalence, associated factors, management and outcomes of hypokalaemia in hospitalised patients at a South African tertiary centre.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2025

A 16-Year-Old with a Mycoplasma hominis Empyema Post-Lung Transplantation: A Case Report.

Pediatric transplantation·2025

Assessing the barriers and enablers to the implementation of the diagnostic radiographer musculoskeletal X-ray reporting service within the NHS in England: a systematic literature review.

BMC health services research·2023

CBCT in contemporary endodontics.

Australian dental journal·2023

Patients' and clinicians' perspectives towards primary care consultations for shoulder pain: qualitative findings from the Prognostic and Diagnostic Assessment of the Shoulder (PANDA-S) programme.

BMC musculoskeletal disorders·2023

Robust deep learning-based protein sequence design using ProteinMPNN.

Science (New York, N.Y.)·2022

Whole-pelvic Versus Prostate-only Radiotherapy in Clinically Node-negative High-Risk Localised Prostate Cancer: A Systematic Review and Meta-analysis with Reconstructed Individual-patient Data.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Locoregional Recurrence in Breast Cancer: Contemporary Multimodality Management and Future Directions.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Lesion Load Matters: Low-dose Spillage, Oar Impact, and Delivery Efficiency Across Robotic Radiosurgery, Ring-gantry, and C-arm Modalities in Multimetastatic Brain Stereotactic Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Time Trends in Cardiac Doses in 10,000 Patients Receiving Curative Thoracic Radiation Therapy Between 2009 and 2020.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

A Regression Meta-Analysis for Myelopathy in Re-Irradiation of Non-Spinal Cord Tumours.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

The Leaky Pipeline Across Borders: A Cross-sectional Analysis of Gender Parity in Radiation Oncology in Austria and Switzerland.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026

Cortical Hyperexcitability Shapes Large-Scale Brain Dynamics and Behavioral Outcome in Angelman Syndrome.

Biological psychiatry global open science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us